Andrea Roncoli

The paper benchmarks structure prediction models on a new antibody dataset to assess their ability to distinguish binders from decoys, finding moderate success but limitations in epitope localization.

MIMOSA improves de novo antibody design by constraining generative models to known binder interfaces, achieving validated binders on targets where unconstrained methods fail.